Filing summary
Entity and period: The supplied filing is Atlas Crest Investment Corp.’s Form 10-K, not an operating-company 10-K filed by Archer Aviation Inc. It covers Atlas’s period from incorporation on August 26, 2020 through December 31, 2020; filed March 8, 2021. Atlas was a shell SPAC with no operating revenue. Archer information appears in disclosures about the proposed business combination and its risks.
Financial results and position
- Atlas results: No revenue. Net loss was $131,310, comprising $159,947 of operating and formation costs and $69,945 of franchise tax expense, partly offset by a $98,582 unrealized gain on trust investments. Loss from operations was $229,892.
- Cash flow: Operating cash outflow was $564,933; investing cash outflow was $500.0 million, reflecting funds deposited in trust; financing cash inflow was $501.5 million. These figures cover only the period since Atlas’s inception.
- Liquidity and assets: At year-end, Atlas reported $925,923 in cash outside the trust, $1.390 million in current assets, $500.099 million in trust investments, and $501.489 million in total assets. Working capital was $1.261 million. Trust-held public shares subject to redemption were recorded as $496.360 million of temporary equity; reported stockholders’ equity was $5.000 million.
- Debt: The $300,000 non-interest-bearing sponsor note used for IPO expenses was repaid at the IPO closing. Atlas reported no outstanding debt at year-end. No off-balance-sheet arrangements were reported.
- Margins and distributions: Operating or profit margins are not meaningful for Atlas, which had no revenue. Atlas had paid no dividends and did not expect to pay them before a business combination.
- Archer figures disclosed in the filing: Archer reported a 2020 net loss of $24.8 million and approximately $25.8 million in cumulative net losses through December 31, 2020. The filing states Archer expected continuing losses and no significant aircraft deliveries before late 2024/2025 at the earliest.
Material changes and proposed transaction
- Atlas completed its October 30, 2020 IPO, selling 50 million units at $10 each for $500 million gross proceeds, and raised $12 million from a private placement of sponsor warrants. The underwriter’s over-allotment option expired unexercised; 1.875 million founder shares were forfeited, leaving 12.5 million outstanding.
- On February 10, 2021, after year-end, Atlas agreed to combine with Archer at an implied Archer equity value of $2.525 billion. The transaction was expected to close in Q2 2021, subject to approvals and other conditions; the agreement could be terminated if not completed by September 10, 2021.
- A concurrent PIPE was contracted for 60 million shares at $10 per share, or $600 million gross proceeds. Archer’s closing condition required at least $600 million in combined trust-account and PIPE cash after redemptions. The filing does not establish that this financing or the business combination subsequently closed.
- The proposed post-combination structure included Class A shares with one vote per share and Class B shares with ten votes per share. The deal also contemplated up to $17.5 million in business-combination marketing fees and approximately $24 million in Moelis advisory and placement-agent fees, payable upon closing.
Outlook, risks, and unusual items
- Atlas expected its approximately $925,923 of outside-trust cash to support its pre-combination activities and believed it had adequate working capital through a business combination or one year from the filing. If the deal failed, it warned that additional sponsor or other funding might be needed to continue its search.
- Archer’s auditor included a going-concern explanatory paragraph: recurring operating losses and operating cash outflows raised substantial doubt about Archer’s ability to continue as a going concern. Archer’s financial statements did not reflect the proposed transaction. Failure to complete the transaction or obtain other funding could threaten continued operations.
- The filing describes Archer’s early-stage aircraft development, certification, manufacturing, market-adoption, supplier, safety, battery, cybersecurity, intellectual-property, and COVID-19 risks. United Airlines’ conditional purchase order was described as Archer’s only current aircraft order; it remained subject to FAA certification and agreement on material terms.
- Archer disclosed material weaknesses in internal controls over financial reporting, including inadequate accounting staffing and segregation of duties, risk assessment, formal accounting controls, and IT general controls. These weaknesses led to immaterial audit adjustments; remediation efforts were underway, but completion and effectiveness were not assured.
- Other SPAC-specific risks include shareholder redemptions reducing deal cash, possible dilution from founder-share anti-dilution provisions and warrants, conflicts arising from sponsor and adviser affiliations and other SPACs, and the possibility that public warrants expire worthless if no combination is completed within the 24-month period.
- Atlas’s independent auditor gave an unqualified opinion on Atlas’s financial statements. Atlas management reported effective disclosure controls as of December 31, 2020; the filing did not include management’s internal-control assessment, citing the transition period for newly public companies.
Important facts for investors to verify
- Confirm the correct issuer: this is Atlas Crest’s SPAC 10-K, and the Archer financial information is presented in transaction-related risk disclosures, not as Atlas’s operating results.
- Review Archer’s audited financial statements and subsequent filings for its cash position, cash burn, debt, going-concern status, control remediation, and the timing and cost of aircraft development.
- Verify the business-combination closing status, actual PIPE proceeds, shareholder redemptions, cash available after closing, and any changes to deal terms, fees, or governance.
- Assess whether United Airlines’ conditional order became binding, and track FAA certification, manufacturing readiness, delivery timing, and funding needs.
- Check the final transaction materials for dilution, founder-share conversion adjustments, warrant terms, related-party fees, and conflicts of interest.